| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant Systemic Therapies for Patients with Renal Cell Carcinoma: Choosing Treatment Based on Patient-level Characteristics
|
Msaouel, Pavlos
|
|
|
5 |
3 |
p. 265-267
|
article
|
| 2 |
All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others
|
Emmett, Louise
|
|
|
5 |
3 |
p. 283-284
|
article
|
| 3 |
Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology
|
Kalapara, Arveen A.
|
|
|
5 |
3 |
p. 314-320
|
article
|
| 4 |
Contents
|
|
|
|
5 |
3 |
p. iii-v
|
article
|
| 5 |
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy
|
Bravi, Carlo A.
|
|
|
5 |
3 |
p. 285-295
|
article
|
| 6 |
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer
|
Brastianos, Harry C.
|
|
|
5 |
3 |
p. 362-365
|
article
|
| 7 |
Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Soeterik, Timo F.W.
|
|
|
5 |
3 |
p. 328-337
|
article
|
| 8 |
Editorial Board
|
|
|
|
5 |
3 |
p. i-ii
|
article
|
| 9 |
[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature
|
Evangelista, Laura
|
|
|
5 |
3 |
p. 273-282
|
article
|
| 10 |
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature
|
Aragaki, Adam K.
|
|
|
5 |
3 |
p. 338-346
|
article
|
| 11 |
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes
|
Hensley, Patrick J.
|
|
|
5 |
3 |
p. 347-356
|
article
|
| 12 |
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
|
Campbell, Shauna R.
|
|
|
5 |
3 |
p. 304-313
|
article
|
| 13 |
Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–directed Transperineal Biopsy
|
Bajeot, Anne-Sophie
|
|
|
5 |
3 |
p. 296-303
|
article
|
| 14 |
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer
|
Steuber, Thomas
|
|
|
5 |
3 |
p. 321-327
|
article
|
| 15 |
Re: Armando Stabile, Antony Pellegrino, Elio Mazzone, et al. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Eur Urol Oncol 2022;5:1–17
|
Chen, Kenneth
|
|
|
5 |
3 |
p. 375-376
|
article
|
| 16 |
Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer
|
Voskuilen, Charlotte S.
|
|
|
5 |
3 |
p. 366-369
|
article
|
| 17 |
Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor–based Dual Combination Therapy
|
Graafland, Niels M.
|
|
|
5 |
3 |
p. 373-374
|
article
|
| 18 |
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy
|
Martini, Alberto
|
|
|
5 |
3 |
p. 370-372
|
article
|
| 19 |
Three-dimensional Magnetic Resonance Imaging–based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy—A Feasibility Study
|
Darr, Christopher
|
|
|
5 |
3 |
p. 357-361
|
article
|
| 20 |
Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non–muscle-invasive Bladder Cancer
|
Giannarini, Gianluca
|
|
|
5 |
3 |
p. 268-272
|
article
|
Journal description